ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEPHEN DAVIS M.D.

Endocrinology, Diabetes Metabolism

9,739

$615K

540
465 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 43%

$63
Average prescription price

Avg: $113

BOBBY JOHNSON MD

Endocrinology, Diabetes Metabolism

8,591

$1.22M

678
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 43%

$142
Average prescription price

Avg: $113

HUEY MCDANIEL M.D.

Endocrinology, Diabetes Metabolism

8,400

$707K

587
389 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 4%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 43%

$84
Average prescription price

Avg: $113

WILLIAM DEBELL M.D.

Endocrinology, Diabetes Metabolism

8,334

$528K

308
200 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

20%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 43%

$63
Average prescription price

Avg: $113

CHRISTINE HECKEMEYER M.D.

Endocrinology, Diabetes Metabolism

8,276

$581K

396
175 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

27%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 43%

$70
Average prescription price

Avg: $113

STEVEN COWART M.D.

Endocrinology, Diabetes Metabolism

7,754

$1.15M

684
434 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 43%

$149
Average prescription price

Avg: $113

MALEK KARASSI M.D.

Endocrinology, Diabetes Metabolism

7,366

$568K

428
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 43%

$77
Average prescription price

Avg: $113

RALPH TEAGUE M.D.

Endocrinology, Diabetes Metabolism

7,184

$634K

398
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 43%

$88
Average prescription price

Avg: $113

ANITA KEMMERLY M.D.

Endocrinology, Diabetes Metabolism

7,016

$881K

471
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 43%

$126
Average prescription price

Avg: $113

LIANKE MU M.D.

Endocrinology, Diabetes Metabolism

6,263

$526K

348
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 43%

$84
Average prescription price

Avg: $113

RUTH MILLER-FROST M.D

Endocrinology, Diabetes Metabolism

6,120

$442K

339
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 4%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 43%

$72
Average prescription price

Avg: $113

JUDSON MENEFEE MD

Endocrinology, Diabetes Metabolism

6,101

$887K

550
415 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 43%

$145
Average prescription price

Avg: $113

JOHN STONE M.D.

Endocrinology, Diabetes Metabolism

6,053

$708K

578
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 43%

$117
Average prescription price

Avg: $113

ROBERT CHADBAND M.D.

Endocrinology, Diabetes Metabolism

5,680

$407K

318
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 43%

$72
Average prescription price

Avg: $113

BANTWAL BALIGA M.D.

Endocrinology, Diabetes Metabolism

5,599

$634K

576
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 43%

$113
Average prescription price

Avg: $113

DOMINIC HOMAN M.D.

Endocrinology, Diabetes Metabolism

5,420

$732K

419
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 43%

$135
Average prescription price

Avg: $113

STEVEN WISE M.D.

Endocrinology, Diabetes Metabolism

5,319

$688K

524
329 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 43%

$129
Average prescription price

Avg: $113

MONICA CARDENAS-GONZALEZ MD

Endocrinology, Diabetes Metabolism

4,981

$857K

533
310 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 43%

$172
Average prescription price

Avg: $113

SYED AHMED MD

Endocrinology, Diabetes Metabolism

4,823

$683K

530
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 43%

$142
Average prescription price

Avg: $113

AKINOLA AYODEJI M.D.

Endocrinology, Diabetes Metabolism

4,535

$509K

496
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 43%

$112
Average prescription price

Avg: $113

MICHAEL ROWLAND M.D.

Endocrinology, Diabetes Metabolism

4,251

$409K

332
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 43%

$96
Average prescription price

Avg: $113

ROSS DEL FIERRO M.D.

Endocrinology, Diabetes Metabolism

3,863

$605K

363
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 43%

$157
Average prescription price

Avg: $113

ELIZABETH VAN BLOMMESTEYN STAHL M.D.

Endocrinology, Diabetes Metabolism

3,538

$345K

236
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 43%

$97
Average prescription price

Avg: $113

RODRIGO VALDERRAMA MD

Endocrinology, Diabetes Metabolism

3,486

$474K

380
213 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 43%

$136
Average prescription price

Avg: $113

FARAH GHORI-JAVED M.D

Endocrinology, Diabetes Metabolism

3,454

$345K

295
191 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 43%

$100
Average prescription price

Avg: $113

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank